REIN THERAPEUTICS, INC. (RNTX) Free cash flow 2017–2021
REIN THERAPEUTICS, INC. (RNTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$23.9MFY2021 · since FY2017: -$20.7M → -$23.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -$23.9M | -16.7% |
| FY2020 | -$20.5M | +23.1% |
| FY2019 | -$26.6M | +17.7% |
| FY2018 | -$32.3M | -56.5% |
| FY2017 | -$20.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice